
Sign up to save your podcasts
Or


Richard Oram explains how recent advances have meant we can now delay type 1 diabetes with immunotherapy. To do this we need to be able to identify people at very high risk of developing Type 1 diabetes. Richard thinks genetic analysis could play a part in this identification.
Send us a text
By Andrew Hattersley and Maggie Shepherd5
66 ratings
Richard Oram explains how recent advances have meant we can now delay type 1 diabetes with immunotherapy. To do this we need to be able to identify people at very high risk of developing Type 1 diabetes. Richard thinks genetic analysis could play a part in this identification.
Send us a text

91,052 Listeners

884 Listeners

102 Listeners

2,546 Listeners

5,174 Listeners

3,110 Listeners

2,078 Listeners

12 Listeners

4 Listeners